Jeffrey Other Name Singer, MA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1811 Nw 124th Ave, Coral Springs, FL 33071 Phone: 954-346-4067 |
Sarah Francis, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5411 N University Dr, Suite 102, Coral Springs, FL 33067 Phone: 954-752-1559 |
Vanessa Rando, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5411 N University Dr, Ste 102, Coral Springs, FL 33067 Phone: 954-752-1559 |
Mr. Anthony James Jelley, MJ.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5491 N University Dr, Suite 101, Coral Springs, FL 33067 Phone: 954-227-2779 Fax: 954-345-8166 |
Dr. Gabrielle Leah Doobrow Audiologist Medicare: Medicare Enrolled Practice Location: 9160b Wiles Rd, Coral Springs, FL 33067 Phone: 954-345-5818 |
J. Audiology, Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5491 N University Dr Ste 101, Coral Springs, FL 33067 Phone: 954-227-2779 Fax: 954-345-8166 |
Mrs. Marifran Christina Ramaglia, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 9160b Wiles Rd, Coral Springs, FL 33067 Phone: 954-345-5818 Fax: 954-345-7940 |
Advanced Audiology Pllc Audiologist Medicare: Medicare Enrolled Practice Location: 9160b Wiles Rd, Coral Springs, FL 33067 Phone: 954-345-5818 Fax: 954-345-7940 |
Dr. Victoria Ann Rojas-schopper, AU.D., R.N. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5511 N University Dr Ste 101b, Coral Springs, FL 33067 Phone: 954-755-4002 Fax: 954-755-5010 |
Advanced Audiology Of South Florida Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9160b Wiles Rd, Coral Springs, FL 33067 Phone: 954-345-5818 Fax: 954-345-7940 |
Audiology Associates Of South Florida Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 5411 N University Dr, Suite 102, Coral Springs, FL 33067 Phone: 954-752-1559 Fax: 954-752-1560 |
News Archive
BioScrip, Inc. today announced 2011 second quarter financial results. Second quarter revenue for the period ended June 30, 2011, was $441.4 million with a net loss of $2.3 million, or $0.04 per share, including $8.7 million in restructuring charges and a legal settlement. Excluding the after tax effect of these charges, the Company earned $0.10 per diluted share. Adjusted EBITDA for the second quarter was $18.1 million.
The U.S. Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate and high risk cancer diagnoses raises concern because of the potential for delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators reporting in The Journal of Urology.
If the very thought of heights, touching a spider or riding in an elevator makes you feel sick, then researchers at The University of Queensland may be able to help.
DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects.
On September 5, 2018 Professor Sebastien Ourselin, Head of the School of Biomedical Engineering & Imaging Sciences at King's College London spoke at the 2018 FORUM Annual Lecture, 'Transforming healthcare through engineering and technology'.
› Verified 1 days ago